Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaginal HRT tablets to become available over the counter

February 3, 2022
Business Services

Vaginal oestrogen tablets, a type of hormone replacement therapy (HRT) – could become available in chemists soon, depending on the …

News

Illumina to advance precision medicine approach for late-stage cancer patients

February 3, 2022
Business Services

Illumina announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University in France, to assess the clinical value …

News

CMA fines firms £35m for illegal arrangement

February 3, 2022
Business Services

The Competition and Markets Authority (CMA) has fined firms over £35 million for an illegal arrangement in the supply of …

News

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022
Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …

News

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022
Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …

News

FDA approval of six-annual-dose HIV treatment

February 2, 2022
Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for

News

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022
Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …

News

Technology on trial – the latest cogs in the clinical machine

February 1, 2022

From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …

Feature

Access denied: Is Brexit spelling bedlam for UK clinical trials?

February 1, 2022

Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …

Feature

Measles jab rate in England falls to ten percent below recommended rate

February 1, 2022
Medical Communications

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …

News

AI technology has the potential for breast cancer diagnosis

February 1, 2022
Manufacturing and Production

Academics at King’s College, London, and Guy’s and St Thomas’ NHS Foundation Trust, are using historical scans in a new …

News

WHO: COVID-19 hospital waste presents health threat

February 1, 2022
Manufacturing and Production

The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …

News

RDIF, AstraZeneca and others invest in treatments for resistant arterial hypertension

February 1, 2022
Medical Communications

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), AstraZeneca, and Unicorn Capital Partners, a biotech-specialised VC fund, announced …

News

FDA approves Vabysmo to treat vision-threatening retinal conditions

January 31, 2022
Sales and Marketing

The FDA has approved vabysmo (faricimab-svoa) for the treatment of neovascular or “wet” age-related macular degeneration and diabetic macular edema. …

News

Almirall announces licensing agreement to accelerate antibody drug discovery

January 31, 2022
Sales and Marketing

Almirall has announced a multi-target licensing agreement with Ablexis, focussed on licensing its AlivaMab Mouse technology, and a research collaboration …

News

Positive CHMP opinion for treatment of rare unpredictable disease

January 31, 2022
Sales and Marketing

Blueprint Medicines has announced that the CHMP has adopted a positive opinion recommending to expand the current indication for AYVAKYT® …

News

CHMP recommends approval of dupixent for children with severe asthma

January 31, 2022
Sales and Marketing

The EMA’s CHMP has adopted a positive opinion recommending the extension of the approval of Dupixent (dupilumab) for children with …

News

Supplemental NDA accepted for leukaemia treatment in China

January 28, 2022
Medical Communications

BeiGene, focused on developing innovative and affordable medicines, announced that the Center for Drug Evaluation (CDE) of the China National …

News

India: DCGI approval for trialling of nasal COVID-19 vaccine

January 28, 2022
Medical Communications

The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …

News

Launch of pioneering platform to accelerate mental health treatment discovery

January 28, 2022

The clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, atai Life Sciences, has launched a platform …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025